Description
P53 Phase III clinical trials with amustaline/glutathione (S-303/GSH) pathogen-inactivated RBC
Article: P53 Phase III clinical trials with amustaline/glutathione (S-303/GSH) pathogen-inactivated RBC
€3.03
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart
